On August 5, 2026, Shell plc purchased a total of 1,625,000 of its own shares across multiple trading venues including the London Stock Exchange and Chi-X, with prices ranging from £32.74 to £33.47 and €38.33 to €39.16. These shares are bought for cancellation as part of Shell's existing share buy-back program announced on July 30, 2026. The buy-back is managed by Goldman Sachs International independently within set parameters and complies with UK and EU market regulations. This move aims to reduce the number of shares outstanding, potentially boosting shareholder value and earnings per share.
On August 4, 2026, Shell plc repurchased a total of 1,625,000 of its own shares across multiple trading venues, including the London Stock Exchange and European markets. These shares are being bought back for cancellation under Shell's existing buy-b...
On August 3, 2026, Shell plc repurchased a total of 1,550,000 shares for cancellation across multiple trading venues including LSE, Chi-X, and XAMS. The buy-back is part of Shell's existing share repurchase program announced on July 30, 2026, managed...
The FTSE 100 fell 30 points to 10,838, dragged down by AstraZeneca's 9.3% drop following reports of merger talks with Bristol Myers Squibb, which raised concerns over strategic fit and antitrust issues. Commodity giants like Rio Tinto and BP also dec...
On July 31, 2026, Shell plc repurchased a total of 1,530,000 shares for cancellation across different trading venues, including the London Stock Exchange and Euronext Amsterdam. This buyback is part of Shell's existing share repurchase program announ...
The FTSE 100 rose slightly to 10,888 points despite AstraZeneca shares dropping 7% due to merger talks with Bristol Myers Squibb, which face regulatory scrutiny. Shell agreed to sell its European onshore renewables business to TotalEnergies, reflecti...
